The GlaxoSmithKline controversy opened the doors of investigation about the misconduct happening in the pharmaceutical industry.
GlaxoSmithKline
Breaking News
China's Commerce Ministry confident probe on drugmaker GlaxoSmithKline won't mar investor confidence
China remains confident that the ongoing investigations for alleged bribery of GSK execs in its China division won't mar investor confidence.
GlaxoSmithKline's plans to raise stakes in GSK Consumer Nigeria on hold after shareholder opposition.
GlaxoSmithKline Plc's 20% increase in sales was currently in focus due to Public Security Ministry's accusations on bribery and sexual favors.
Sources revealed that AG Barr could be buying GlaxoSmithKline's Ribena and Lucozade brands.
GSK was offered a formal takeover bid priced more than a billion pounds for its soft drink brand Lucozade and Ribena by Blackstone and Lion Capital.
Bids, mergers, acquisitions and disposals involving European, U.S. and Asian companies.
1 2
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- UPDATE: Google Employees Arrested and Fired After Staging Protests Over Company's Project Nimbus Deal With Israel
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Navigating Tariff Tides: A Conversation with Jim Pratt on Supply Chain Strategies Ahead of 2024 Elections
